Literature DB >> 19952321

Assessment of claims of improved prediction beyond the Framingham risk score.

Ioanna Tzoulaki1, George Liberopoulos, John P A Ioannidis.   

Abstract

CONTEXT: With heightened interest in predictive medicine, many studies try to document information that can improve prediction of major clinical outcomes.
OBJECTIVE: To evaluate the reported design and analysis of studies that examined whether additional predictors improve predictive performance when added to the Framingham risk score (FRS), one of the most widely validated and cited clinical prediction scores. STUDY SELECTION: Two independent investigators searched 1908 articles citing the article that described the FRS in 1998 until September 2009 through the ISI Web of Knowledge database. Articles were eligible if they included any analyses comparing the predictive performance of the FRS vs the FRS plus some additional predictor for a prospectively assessed outcome. Data Analyses We recorded information on FRS calculation, modeling of additional predictors, outcomes assessed, population evaluated, subgroup analysis documentation, and flaws in the methods that may have affected the reported improvements in predictive ability. We also evaluated the correlation of reported design and analysis features with the predictive model discrimination and improvements with the additional predictors.
RESULTS: We evaluated 79 eligible articles. Forty-nine studies (62%) did not calculate the FRS as it has been proposed, 15 (19%) modeled the additional predictor in more than 1 way and presented only the best-fit or area-under-the-curve (AUC) results for only 1 model, 41 (52%) did not examine the original outcome that the FRS was developed for, 33 (42%) studied a population different from what the FRS was intended for, and 25 (32%) claimed improved prediction in 1 subgroup but only 7 (9%) formally tested subgroup differences. Evaluation of independence in multivariable regressions, discrimination in AUC, calibration, and reclassification were reported in 77, 36, 7, and 7 studies, respectively, but these methods were adequately documented in only 60, 13, 4, and 2 studies, respectively. Overall, 63 studies (80%) claimed some improved prediction. Increase in AUC was larger when the predictive performance of the FRS was lower (rho = -0.57, P < .001). Increase in AUC was significantly larger when evaluation of independence in multivariable regression or discrimination in AUC analysis was not adequately documented and when the additional predictor had been modeled in more than 1 way and only 1 model was reported for AUC.
CONCLUSION: The majority of examined studies claimed that they found factors that could offer additional predictive value beyond what the FRS could achieve; however, most had flaws in their design, analyses, and reporting that cast some doubt on the reliability of the claims for improved prediction.

Mesh:

Year:  2009        PMID: 19952321     DOI: 10.1001/jama.2009.1757

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  104 in total

1.  Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models.

Authors:  Michael J Pencina; Ralph B D'Agostino; Olga V Demler
Journal:  Stat Med       Date:  2011-12-07       Impact factor: 2.373

2.  Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  BMC Med       Date:  2012-05-29       Impact factor: 8.775

3.  Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  PLoS Med       Date:  2012-05-29       Impact factor: 11.069

Review 4.  Thermal provocation to evaluate microvascular reactivity in human skin.

Authors:  Christopher T Minson
Journal:  J Appl Physiol (1985)       Date:  2010-05-27

5.  The diagnostic performance of the Mass Restricted (MR) score in the identification of microbial invasion of the amniotic cavity or intra-amniotic inflammation is not superior to amniotic fluid interleukin-6.

Authors:  Roberto Romero; Nicholas Kadar; Jezid Miranda; Steven J Korzeniewski; Alyse G Schwartz; Piya Chaemsaithong; Wade Rogers; Eleazar Soto; Francesca Gotsch; Lami Yeo; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2013-12-16

6.  Family history and body mass index predict perceived risks of diabetes and heart attack among community-dwelling Caucasian, Filipino, Korean, and Latino Americans--DiLH Survey.

Authors:  Yoshimi Fukuoka; JiWon Choi; Melinda S Bender; Prisila Gonzalez; Shoshana Arai
Journal:  Diabetes Res Clin Pract       Date:  2015-04-20       Impact factor: 5.602

7.  Utility of Framingham risk score in urban emergency department patients with asymptomatic hypertension.

Authors:  Aaron M Brody; John M Flack; Brian A Ference; Phillip D Levy
Journal:  Crit Pathw Cardiol       Date:  2014-09

8.  Health risk prediction models incorporating personality data: Motivation, challenges, and illustration.

Authors:  Benjamin P Chapman; Feng Lin; Shumita Roy; Ralph H B Benedict; Jeffrey M Lyness
Journal:  Personal Disord       Date:  2019-01

9.  Predictive Accuracy of a Polygenic Risk Score-Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery Disease.

Authors:  Joshua Elliott; Barbara Bodinier; Tom A Bond; Marc Chadeau-Hyam; Evangelos Evangelou; Karel G M Moons; Abbas Dehghan; David C Muller; Paul Elliott; Ioanna Tzoulaki
Journal:  JAMA       Date:  2020-02-18       Impact factor: 56.272

10.  Understanding increments in model performance metrics.

Authors:  Michael J Pencina; Ralph B D'Agostino; Joseph M Massaro
Journal:  Lifetime Data Anal       Date:  2012-12-16       Impact factor: 1.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.